INFLUENCE OF RESISTIN ON THE COURSE OF ISCHEMIC HEART DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

QR Code

INFLUENCE OF RESISTIN ON THE COURSE OF ISCHEMIC HEART DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Relevance. Through dermal coronary intravascular revascularization by means of stenting is an effective method of treatment CHD patients with the type 2 diabets. At the same time frequency of stents restenosing for this special cohort of patients is fluctuating from 12 by 40 %.Objective. To study pr...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. T. Teplyakov, Sh. D. Akhmedov, T. Ye. Suslova, А. V. Andriyanova, A. V. Kuznetsova, N. V. Protopopova, V. V. Kalyuzhin, O. N. Nasanova
Format:	Article
Language:	English
Published:	Siberian State Medical University (Tomsk) 2015-10-01
Series:	Бюллетень сибирской медицины
Subjects:	resistin coronary restenosis stenting type 2 diabetes mellitus risk stratification
Online Access:	https://bulletin.ssmu.ru/jour/article/view/190
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Estimation of Salivary Resistin, malondialdehyde and Lipid Profile levels in patients with Diabetes Mellitus
by: Entedhar R. Sarhat, et al.
Published: (2023-02-01)

Relationship between serum Nesfatin-1, Adiponectin, Resistin Concentration, and Obesity with Type 2 Diabetes Mellitus
by: Baydaa Ahmed Abed, et al.
Published: (2024-01-01)

DIABETIC CARDIOMYOPATHY. RESISTIN: A CONTROL OF A MYOCARDIAL HYPERTROPHY
by: An. A. Aleksandrov, et al.
Published: (2015-09-01)

Лечение коронарного атеросклероза: влияние массового применения стентов на ближайшие и отдаленные результаты коронарной ангиопластики
by: А. М. Бабунашвили, et al.
Published: (2011-02-01)

Effects of Extracted Phenolic Compounds from Grape Seeds on Leptin, Adiponectin and Resistin Levels in Rats Fed with High Fat Foods
by: Entedhar Rifaat Sarhat, et al.
Published: (2018-04-01)

Clinical condition and cardiovascular risk factors displaying neoatherosclerosis in stented coronary arteries with developing restenosis
by: V. P. Mazaev, et al.
Published: (2016-10-01)

Adipokines resistin and lipokalin-2 and its role in the pathogenesis of polycystic ovary syndrome and metabolic syndrome.
by: N. Yu. Voronenko
Published: (2013-10-01)

PREDICTORS OF CORONARY ARTERIES RESTENOSIS AFTER STENTING IN OBESE WOMEN
by: N. G. Veselovskaya, et al.
Published: (2014-09-01)

Risk assessment score for drug eluting stent restenosis
by: Z. A. Gabbasov, et al.
Published: (2018-09-01)

Assessment of lipocalin-1, resistin, cathepsin-D, neurokinin A, agmatine, NGF, and BDNF serum levels in children with Autism Spectrum Disorder
by: Tahiroğlu Veysel, et al.
Published: (2025-04-01)

Optical coherence tomography in differential diagnosis of the morphology of in-stent restenosis and neoaterosclerosis
by: V. N. Fomin, et al.
Published: (2020-11-01)

Angioplasty and carotid artery stenting: clinical and morphological factors affecting long-term outcomes
by: F. B. Shukurov, et al.
Published: (2020-07-01)

Safety and Efficacy of Cobalt Chromium Everolimus‐Eluting Stents for Treatment of In‐Stent Restenosis: An ILUMIEN IV Substudy
by: Ziad A. Ali, et al.
Published: (2025-06-01)

Evaluating the Linkage Between Resistin and Viral Seropositivity in Psoriasis: Evidence from a Tertiary Centre
by: Habeeb Ali Baig, et al.
Published: (2025-06-01)

Clinical and angiography factors influencing long-term coronary stenting results
by: S. O. Sokolova, et al.
Published: (2005-08-01)

Restenosis risk factors after coronary stenting in metabolic syndrome patients
by: N. M. Danilov, et al.
Published: (2007-04-01)

CLINIC EFFICIENCY OF MYOCARDIAL REVASCULARIZATION FOR CARDIAC ALLOGRAFT VASCULOPATHY
by: B. L. Mironkov, et al.
Published: (2014-12-01)

Effects of cilostazol for in-stent restenosis after carotid artery stenting: a meta-analysis
by: Jing Sun, et al.
Published: (2025-06-01)

Clinical and Laboratory Predictors of Major Adverse Cardiac Events in Patients with Ischemic Heart Disease Following Elective Percutaneous Coronary Intervention
by: E. Z. Golukhova, et al.
Published: (2016-11-01)

Stent Failure Management in Contemporary Clinical Practice
by: Iosif Xenogiannis, et al.
Published: (2025-07-01)

Current Techniques of Intravascular Imaging and Implantation of Bioresorbable Coronary Vascular Scaffolds (Stents)
by: I. E. Nikolaeva, et al.
Published: (2019-07-01)

LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN CARDIOVASCULAR RISK STRATIFICATION AFTER CORONARY ANGIOPLASTY IN PATIENTS WITH TYPE 2 DIABETES: WHICH DECISION RULE THRESHOLD TO CHOOSE?
by: A. T. Teplyakov, et al.
Published: (2015-04-01)

A Subtraction Coronary Computed Tomography Angiography Technique to Evaluate In-stent Restenosis
by: Yan ZHOU, et al.
Published: (2025-07-01)

RESTENOSIS AND IN-STENT STENOSIS: PATHOGENETIC MECHANISMS AND PROGNOSTIC MARKERS
by: G. A. Berezovskaya, et al.
Published: (2012-12-01)

Percutaneous coronary intervention using various types of stents in acute coronary syndrome without st segment elevation in patients with type 2 diabetes mellitus: long-term results
by: A. R. Al-Sulami, et al.
Published: (2025-03-01)

Restenosis pathophysiological mechanisms and genetic markers after percutaneous coronary interventions
by: Yu. A. Shuvalova, et al.
Published: (2007-10-01)

Role of early increase in vascular endothelial growth factor-A levels after coronary stenting in the development of drug-eluting in-stent restenosis
by: V. V. Tishko, et al.
Published: (2024-06-01)

Risk stratification in patients with unstable angina and diabetes mellitus
by: R. D. Kurbanov, et al.
Published: (2008-12-01)

Neoatherosclerosis in the stent
by: A. A. Komkov, et al.
Published: (2015-12-01)

The predictive value of preprocedural laboratory data in patients with coronary artery restenosis in various types of stents
by: D. V. Shames, et al.
Published: (2019-04-01)

How real is a threat of late thrombosis for drug-eluting stents? Stent comparison and focus on everolimus
by: V. P. Lupanov, et al.
Published: (2009-10-01)

Thrombosis prevention in percutaneous coronary interventions
by: V. P. Lupanov, et al.
Published: (2009-08-01)

Impact of Arterial Stiffness on In-Stent Restenosis in the Era of Drug-Eluting Stents
by: Yiquan Huang, et al.
Published: (2025-06-01)

Comparison of the Efficacy of Everolimus-Eluting Stents and Paclitaxel-Eluting Balloon Angioplasty for Coronary In-Stent Restenosis: A Systematic Review and Meta-Analysis
by: Zhili Wei, et al.
Published: (2025-06-01)

Antioxidant system gene polymorphism and restenosis risk after coronary stenting
by: Yu. A. Shuvalova, et al.
Published: (2008-10-01)

Resistin secreted by porcine alveolar macrophages leads to endothelial cell dysfunction during Haemophilus parasuis infection
by: Kexin Hua, et al.
Published: (2023-12-01)

Effect of Neoatherosclerosis and Intervention‐Associated Neoatheroma Rupture on Clinical Outcomes in Patients With In‐Stent Restenosis: A Retrospective Study
by: Xiao‐Xia Zhang, et al.
Published: (2025-07-01)

Research advances in the etiology of in-stent restenosis of coronary arteries
by: Hangrui Bai, et al.
Published: (2025-07-01)

Recurrent ischemia after percutaneous coronary intervention
by: M. P. Malgina, et al.
Published: (1970-01-01)

Elevated Lipoprotein(a) Predicts Stent Edge Restenosis and Adverse Two-Year Outcomes After PCI: An Intravascular Ultrasound Study
by: Wu X, et al.
Published: (2025-07-01)